Chronic Treatment with a Promnesiant GABA-A -Selective Inverse Agonist Increases Immediate Early Genes Expression during Memory Processing in Mice and Rectifies Their Expression Levels in a Down Syndrome Mouse Model
Advances in Pharmacological Sciences · 2011 · 2011 · 1-11
DOI: 10.1155/2011/153218 ↗Abstract
Decrease of GABAergic transmission has been proposed to improve memory functions. Indeed, inverse agonists selective for α 5 GABA-A-benzodiazepine receptors ( α 5IA) have promnesiant activity. Interestingly, we have recently shown that α 5IA can rescue cognitive deficits in Ts65Dn mice, a Down syndrome mouse model with altered GABAergic transmission. Here, we studied the impact of chronic treatment with α 5IA on gene expression in the hippocampus of Ts65Dn and control euploid mice after being trained in the Morris water maze task. In euploid mice, chronic treatment with α 5IA increased IEGs expression, particularly of c-Fos and Arc genes. In Ts65Dn mice, deficits of IEGs activation were completely rescued after treatment with α 5IA. In addition, normalization of Sod1 overexpression in Ts65Dn mice after α 5IA treatment was observed. IEG expression regulation after α 5IA treatment following behavioral stimulation could be a contributing factor for both the general promnesiant activity of α 5IA and its rescuing effect in Ts65Dn mice alongside signaling cascades that are critical for memory consolidation and cognition.
EUVIMED